[Progressive multifocal leukoencephalopathy after natalizumab therapy].

Suppr

超能文献

作者信息

Schmitt Christian, Bensussan Armand

出版信息

Med Sci (Paris). 2005 Oct;21(10):797-8. doi: 10.1051/medsci/20052110797.

DOI:10.1051/medsci/20052110797

PMID:16197890

Abstract

摘要

相似文献

[Progressive multifocal leukoencephalopathy after natalizumab therapy].

Med Sci (Paris). 2005 Oct;21(10):797-8. doi: 10.1051/medsci/20052110797.

Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.

N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6. doi: 10.1056/NEJMc052311.

Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.

Neurology. 2007 Aug 14;69(7):704-6. doi: 10.1212/01.wnl.0000267325.06000.d9.

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

N Engl J Med. 2005 Jul 28;353(4):414-6. doi: 10.1056/NEJMe058122. Epub 2005 Jun 9.

Natalizumab for relapsing multiple sclerosis.

N Engl J Med. 2006 Jun 1;354(22):2387-9; author reply 2387-9.

Balancing risk and reward: the question of natalizumab.

Ann Neurol. 2009 Sep;66(3):A7-8. doi: 10.1002/ana.21873.

Natalizumab and progressive multifocal leukoencephalopathy.

N Engl J Med. 2005 Jul 28;353(4):432-3. doi: 10.1056/NEJMc055235. Epub 2005 Jun 9.

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

N Engl J Med. 2009 Sep 10;361(11):1075-80. doi: 10.1056/NEJMoa0810257.

[Natalizumab in multiple sclerosis: unclear patient benefits].

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):852-5.

Interruption of natalizumab therapy for multiple sclerosis: what are the risks?

Neurology. 2011 May 31;76(22):1854-5. doi: 10.1212/WNL.0b013e31821d7553. Epub 2011 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Progressive multifocal leukoencephalopathy after natalizumab therapy].

Med Sci (Paris). 2005 Oct;21(10):797-8. doi: 10.1051/medsci/20052110797.

Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.

N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6. doi: 10.1056/NEJMc052311.

Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.

Neurology. 2007 Aug 14;69(7):704-6. doi: 10.1212/01.wnl.0000267325.06000.d9.

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

N Engl J Med. 2005 Jul 28;353(4):414-6. doi: 10.1056/NEJMe058122. Epub 2005 Jun 9.

Natalizumab for relapsing multiple sclerosis.

N Engl J Med. 2006 Jun 1;354(22):2387-9; author reply 2387-9.

Balancing risk and reward: the question of natalizumab.

Ann Neurol. 2009 Sep;66(3):A7-8. doi: 10.1002/ana.21873.

Natalizumab and progressive multifocal leukoencephalopathy.

N Engl J Med. 2005 Jul 28;353(4):432-3. doi: 10.1056/NEJMc055235. Epub 2005 Jun 9.

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

N Engl J Med. 2009 Sep 10;361(11):1075-80. doi: 10.1056/NEJMoa0810257.

[Natalizumab in multiple sclerosis: unclear patient benefits].

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):852-5.

Interruption of natalizumab therapy for multiple sclerosis: what are the risks?

Neurology. 2011 May 31;76(22):1854-5. doi: 10.1212/WNL.0b013e31821d7553. Epub 2011 May 4.